GCC continuous glucose monitoring devices market report size, share, growth drivers, trends, opportunities & forecast 2025–2030

GCC Continuous Glucose Monitoring Devices Market Overview

• The GCC Continuous Glucose Monitoring Devices Market is valued at USD 120 million, based on a five-year historical analysis. This growth is primarily driven by the rising prevalence of diabetes in the region, increasing adoption of wearable and minimally invasive glucose monitoring technologies, and a shift toward personalized diabetes management. The market is further supported by greater awareness of diabetes complications, government-led screening programs, and the integration of digital health platforms with CGM devices, which enhance both usability and patient engagement .
• Key players in this market include Saudi Arabia and the UAE, which dominate due to their robust healthcare infrastructure, high disposable incomes, and government initiatives aimed at improving diabetes care. The presence of leading medical device manufacturers, rapid urbanization, and a growing population of diabetic patients further contribute to their market leadership .
• The Medical Devices Interim Regulation, issued by the Saudi Food and Drug Authority (SFDA) in 2021, mandates that all continuous glucose monitoring devices must be registered with the SFDA before being marketed in Saudi Arabia. This regulation requires manufacturers and importers to comply with safety, efficacy, and quality standards, and to obtain pre-market approval for each device model, thereby enhancing patient safety and promoting better health outcomes .

GCC Continuous Glucose Monitoring Devices Market Segmentation

By Type:The segmentation by type includes various components essential for continuous glucose monitoring. The subsegments are Sensors, Transmitters, Receivers/Monitors, and Integrated/Smart CGM Systems. Among these,Sensorsare the most dominant due to their critical role in measuring glucose levels accurately and continuously, which is essential for effective diabetes management. The increasing demand for real-time data, advancements in sensor technology, and the introduction of needle-free and long-wear sensors are driving this segment's growth .

By End-User:The end-user segmentation includes Hospitals, Home healthcare, Diabetes clinics, Diagnostic laboratories, and Others.Hospitalsare the leading end-user segment, driven by the increasing number of diabetes patients requiring hospitalization and the growing adoption of advanced monitoring technologies in clinical settings. The trend towards outpatient care and home monitoring is also contributing to the growth of home healthcare services, with home healthcare emerging as a rapidly expanding segment due to patient preference for convenience and infection control .

GCC Continuous Glucose Monitoring Devices Market Competitive Landscape

The GCC Continuous Glucose Monitoring Devices Market is characterized by a dynamic mix of regional and international players. Leading participants such as Abbott Laboratories, Dexcom, Inc., Medtronic plc, Roche Diabetes Care, Ascensia Diabetes Care, Senseonics Holdings, Inc., Insulet Corporation, Tandem Diabetes Care, Inc., Nova Biomedical, Ypsomed AG, Glooko, Inc., LifeScan, Inc., B. Braun Melsungen AG, F. Hoffmann-La Roche AG, DarioHealth Corp., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Medisana GmbH, i-SENS, Inc. contribute to innovation, geographic expansion, and service delivery in this space.

GCC Continuous Glucose Monitoring Devices Market Industry Analysis

Growth Drivers

• Increasing Prevalence of Diabetes:The GCC region has witnessed a significant rise in diabetes cases, with approximately 12.2 million adults affected in future. This alarming statistic is projected to increase by 5% annually, driven by lifestyle changes and urbanization. The World Health Organization reported that diabetes prevalence in the Middle East is expected to reach 15% in future, creating a substantial demand for continuous glucose monitoring devices to manage this chronic condition effectively.
• Technological Advancements in Monitoring Devices:The continuous glucose monitoring devices market is being propelled by rapid technological innovations. In future, the introduction of devices featuring real-time data analytics and mobile connectivity has enhanced user experience. The global investment in health tech reached $50 billion in future, with a significant portion directed towards diabetes management technologies. This trend is expected to continue, fostering the development of more efficient and user-friendly monitoring solutions in the GCC.
• Rising Health Awareness Among Consumers:Health awareness campaigns in the GCC have led to a notable increase in consumer knowledge regarding diabetes management. In future, over 60% of the population reported being aware of diabetes risks and management options. Government initiatives and non-profit organizations have invested approximately $200 million in educational programs, promoting the adoption of continuous glucose monitoring devices. This heightened awareness is driving demand for advanced monitoring solutions among consumers.

Market Challenges

• High Cost of Continuous Glucose Monitoring Devices:The affordability of continuous glucose monitoring devices remains a significant barrier in the GCC market. The average cost of these devices is around $1,500, which poses a challenge for many patients, especially in lower-income segments. With healthcare spending in the GCC projected to reach $100 billion in future, the high upfront costs of these devices limit accessibility and adoption among the broader population.
• Limited Reimbursement Policies:Reimbursement policies for continuous glucose monitoring devices in the GCC are often inadequate, hindering market growth. Currently, only 30% of health insurance plans cover these devices, leaving many patients to bear the full cost. As healthcare expenditure in the region is expected to grow by 5% annually, the lack of comprehensive reimbursement options remains a critical challenge that needs addressing to enhance device adoption.

GCC Continuous Glucose Monitoring Devices Market Future Outlook

The future of the GCC continuous glucose monitoring devices market appears promising, driven by technological advancements and increasing health awareness. As the prevalence of diabetes continues to rise, the demand for innovative monitoring solutions is expected to grow. Additionally, the integration of artificial intelligence and telehealth services will likely enhance patient engagement and improve health outcomes. These trends indicate a shift towards more personalized healthcare solutions, positioning the market for significant growth in the coming years.

Market Opportunities

• Expansion of Telehealth Services:The rapid growth of telehealth services in the GCC presents a significant opportunity for continuous glucose monitoring devices. With telehealth consultations projected to increase by 40% in future, integrating glucose monitoring into these services can enhance patient management and accessibility, particularly in remote areas.
• Development of User-Friendly Devices:There is a growing demand for user-friendly continuous glucose monitoring devices that cater to diverse consumer needs. Innovations focusing on ease of use and integration with mobile applications can attract a broader audience, particularly among younger populations, thereby expanding market reach and enhancing user engagement.